{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:22:12Z","timestamp":1791303732937,"version":"4.1.0"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12035-014-8715-8","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T07:36:28Z","timestamp":1398843388000},"page":"406-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Transcription, Epigenetics and Ameliorative Strategies in Huntington\u2019s Disease: a Genome-Wide Perspective"],"prefix":"10.1007","volume":"51","author":[{"given":"Luis M.","family":"Valor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"key":"8715_CR1","unstructured":"Bates G, Harper P, Jones L, editors (2004) Huntington\u2019s disease. 3rd ed: Oxford University Press"},{"issue":"Suppl 1","key":"8715_CR2","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S1353-8020(11)70034-7","volume":"18","author":"H Shang","year":"2012","unstructured":"Shang H, Danek A, Landwehrmeyer B, Burgunder JM (2012) Huntington\u2019s disease: new aspects on phenotype and genotype. Parkinsonism Relat Disord 18(Suppl 1):S107\u2013S109","journal-title":"Parkinsonism Relat Disord"},{"key":"8715_CR3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981","journal-title":"Physiol Rev"},{"key":"8715_CR4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.410420213","volume":"42","author":"SJ Augood","year":"1997","unstructured":"Augood SJ, Faull RL, Emson PC (1997) Dopamine D1 and D2 receptor gene expression in the striatum in Huntington\u2019s disease. Ann Neurol 42:215\u2013221","journal-title":"Ann Neurol"},{"key":"8715_CR5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(80)90237-1","volume":"199","author":"PC Emson","year":"1980","unstructured":"Emson PC, Arregui A, Clement-Jones V, Sandberg BE, Rossor M (1980) Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington\u2019s disease. Brain Res 199:147\u2013160","journal-title":"Brain Res"},{"key":"8715_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","volume":"241","author":"AB Young","year":"1988","unstructured":"Young AB, Greenamyre JT, Hollingsworth Z, Albin R, D'Amato C et al (1988) NMDA receptor losses in putamen from patients with Huntington\u2019s disease. Science 241:981\u2013983","journal-title":"Science"},{"key":"8715_CR7","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","volume":"95","author":"JH Cha","year":"1998","unstructured":"Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L et al (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci U S A 95:6480\u20136485","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR8","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/ddh175","volume":"13","author":"G Schilling","year":"2004","unstructured":"Schilling G, Savonenko AV, Klevytska A, Morton JL, Tucker SM et al (2004) Nuclear-targeting of mutant huntingtin fragments produces Huntington\u2019s disease-like phenotypes in transgenic mice. Hum Mol Genet 13:1599\u20131610","journal-title":"Hum Mol Genet"},{"key":"8715_CR9","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/hmg\/ddi340","volume":"14","author":"CL Benn","year":"2005","unstructured":"Benn CL, Landles C, Li H, Strand AD, Woodman B et al (2005) Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington\u2019s disease. Hum Mol Genet 14:3065\u20133078","journal-title":"Hum Mol Genet"},{"key":"8715_CR10","first-page":"117","volume":"26","author":"AS Harris","year":"2001","unstructured":"Harris AS, Denovan-Wright EM, Hamilton LC, Robertson HA (2001) Protein kinase C beta II mRNA levels decrease in the striatum and cortex of transgenic Huntington\u2019s disease mice. J Psychiatry Neurosci 26:117\u2013122","journal-title":"J Psychiatry Neurosci"},{"key":"8715_CR11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","volume":"123","author":"AL Hebb","year":"2004","unstructured":"Hebb AL, Robertson HA, Denovan-Wright EM (2004) Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington\u2019s disease transgenic mice prior to the onset of motor symptoms. Neuroscience 123:967\u2013981","journal-title":"Neuroscience"},{"key":"8715_CR12","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/hmg\/11.19.2279","volume":"11","author":"H Kita","year":"2002","unstructured":"Kita H, Carmichael J, Swartz J, Muro S, Wyttenbach A et al (2002) Modulation of polyglutamine-induced cell death by genes identified by expression profiling. Hum Mol Genet 11:2279\u20132287","journal-title":"Hum Mol Genet"},{"key":"8715_CR13","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL (2008) The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. J Neurosci 28:14341\u201314346","journal-title":"J Neurosci"},{"key":"8715_CR14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbrc.2010.05.007","volume":"396","author":"M Sinha","year":"2010","unstructured":"Sinha M, Ghose J, Das E, Bhattarcharyya NP (2010) Altered microRNAs in STHdh(Q111)\/Hdh(Q111) cells: miR-146a targets TBP. Biochem Biophys Res Commun 396:742\u2013747","journal-title":"Biochem Biophys Res Commun"},{"key":"8715_CR15","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","volume":"10","author":"A Wyttenbach","year":"2001","unstructured":"Wyttenbach A, Swartz J, Kita H, Thykjaer T, Carmichael J et al (2001) Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington\u2019s disease. Hum Mol Genet 10:1829\u20131845","journal-title":"Hum Mol Genet"},{"key":"8715_CR16","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1093\/nar\/gkq575","volume":"38","author":"E Marti","year":"2010","unstructured":"Marti E, Pantano L, Banez-Coronel M, Llorens F, Minones-Moyano E et al (2010) A myriad of miRNA variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing. Nucleic Acids Res 38:7219\u20137235","journal-title":"Nucleic Acids Res"},{"key":"8715_CR17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1471-4159.2012.07925.x","volume":"123","author":"J Jin","year":"2012","unstructured":"Jin J, Cheng Y, Zhang Y, Wood W, Peng Q et al (2012) Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin. J Neurochem 123:477\u2013490","journal-title":"J Neurochem"},{"key":"8715_CR18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","volume":"227","author":"ST Lee","year":"2011","unstructured":"Lee ST, Chu K, Im WS, Yoon HJ, Im JY et al (2011) Altered microRNA regulation in Huntington\u2019s disease models. Exp Neurol 227:172\u2013179","journal-title":"Exp Neurol"},{"key":"8715_CR19","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/hmg\/ddr111","volume":"20","author":"PM Gaughwin","year":"2011","unstructured":"Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P et al (2011) Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington\u2019s disease. Hum Mol Genet 20:2225\u20132237","journal-title":"Hum Mol Genet"},{"key":"8715_CR20","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1073\/pnas.1221292110","volume":"110","author":"CW Ng","year":"2013","unstructured":"Ng CW, Yildirim F, Yap YS, Dalin S, Matthews BJ et al (2013) Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc Natl Acad Sci U S A 110:2354\u20132359","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR21","doi-asserted-by":"crossref","first-page":"E3027","DOI":"10.1073\/pnas.1311323110","volume":"110","author":"M Vashishtha","year":"2013","unstructured":"Vashishtha M, Ng CW, Yildirim F, Gipson TA, Kratter IH et al (2013) Targeting H3K4 trimethylation in Huntington disease. Proc Natl Acad Sci U S A 110:E3027\u2013E3036","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR et al (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease. Hum Mol Genet 9:1259\u20131271","journal-title":"Hum Mol Genet"},{"key":"8715_CR23","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","volume":"11","author":"R Luthi-Carter","year":"2002","unstructured":"Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W et al (2002) Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 11:1911\u20131926","journal-title":"Hum Mol Genet"},{"key":"8715_CR24","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","volume":"11","author":"R Luthi-Carter","year":"2002","unstructured":"Luthi-Carter R, Strand AD, Hanson SA, Kooperberg C, Schilling G et al (2002) Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington\u2019s disease mouse models reveal context-independent effects. Hum Mol Genet 11:1927\u20131937","journal-title":"Hum Mol Genet"},{"key":"8715_CR25","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","volume":"14","author":"AD Strand","year":"2005","unstructured":"Strand AD, Aragaki AK, Shaw D, Bird T, Holton J et al (2005) Gene expression in Huntington\u2019s disease skeletal muscle: a potential biomarker. Hum Mol Genet 14:1863\u20131876","journal-title":"Hum Mol Genet"},{"key":"8715_CR26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/hmg\/ddi483","volume":"15","author":"G Abou-Sleymane","year":"2006","unstructured":"Abou-Sleymane G, Chalmel F, Helmlinger D, Lardenois A, Thibault C et al (2006) Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program. Hum Mol Genet 15:691\u2013703","journal-title":"Hum Mol Genet"},{"key":"8715_CR27","first-page":"1638","volume":"2","author":"HP Nguyen","year":"2008","unstructured":"Nguyen HP, Metzger S, Holzmann C, Koczan D, Thiesen HJ et al (2008) Age-dependent gene expression profile and protein expression in a transgenic rat model of Huntington\u2019s disease. Proteomics: Clin Appl 2:1638\u20131650","journal-title":"Proteomics: Clin Appl"},{"key":"8715_CR28","doi-asserted-by":"crossref","first-page":"10471","DOI":"10.1523\/JNEUROSCI.0670-13.2013","volume":"33","author":"LM Valor","year":"2013","unstructured":"Valor LM, Guiretti D, Lopez-Atalaya JP, Barco A (2013) Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease. J Neurosci 33:10471\u201310482","journal-title":"J Neurosci"},{"key":"8715_CR29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2202-14-88","volume":"14","author":"J Kocerha","year":"2013","unstructured":"Kocerha J, Liu Y, Willoughby D, Chidamparam K, Benito J et al (2013) Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington\u2019s disease monkeys. BMC Neurosci 14:88","journal-title":"BMC Neurosci"},{"key":"8715_CR30","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1093\/hmg\/ddr355","volume":"20","author":"E Fossale","year":"2011","unstructured":"Fossale E, Seong IS, Coser KR, Shioda T, Kohane IS et al (2011) Differential effects of the Huntington\u2019s disease CAG mutation in striatum and cerebellum are quantitative not qualitative. Hum Mol Genet 20:4258\u20134267","journal-title":"Hum Mol Genet"},{"key":"8715_CR31","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","volume":"11","author":"S Sipione","year":"2002","unstructured":"Sipione S, Rigamonti D, Valenza M, Zuccato C, Conti L et al (2002) Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet 11:1953\u20131965","journal-title":"Hum Mol Genet"},{"key":"8715_CR32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1523\/JNEUROSCI.4522-06.2007","volume":"27","author":"K Tagawa","year":"2007","unstructured":"Tagawa K, Marubuchi S, Qi ML, Enokido Y, Tamura T et al (2007) The induction levels of heat shock protein 70 differentiate the vulnerabilities to mutant huntingtin among neuronal subtypes. J Neurosci 27:868\u2013880","journal-title":"J Neurosci"},{"key":"8715_CR33","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1523\/JNEUROSCI.3044-08.2008","volume":"28","author":"H Runne","year":"2008","unstructured":"Runne H, Regulier E, Kuhn A, Zala D, Gokce O et al (2008) Dysregulation of gene expression in primary neuron models of Huntington\u2019s disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry. J Neurosci 28:9723\u20139731","journal-title":"J Neurosci"},{"key":"8715_CR34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddi443","volume":"15","author":"BL Apostol","year":"2006","unstructured":"Apostol BL, Illes K, Pallos J, Bodai L, Wu J et al (2006) Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1\/2 protects against mutant huntingtin-associated toxicity. Hum Mol Genet 15:273\u2013285","journal-title":"Hum Mol Genet"},{"key":"8715_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2009.06.049","volume":"1286","author":"Y Liang","year":"2009","unstructured":"Liang Y, Jiang H, Ratovitski T, Jie C, Nakamura M et al (2009) ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line. Brain Res 1286:221\u2013229","journal-title":"Brain Res"},{"key":"8715_CR36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T et al (2006) Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet 15:965\u2013977","journal-title":"Hum Mol Genet"},{"key":"8715_CR37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1471-4159.2005.03588.x","volume":"96","author":"PA Desplats","year":"2006","unstructured":"Desplats PA, Kass KE, Gilmartin T, Stanwood GD, Woodward EL et al (2006) Selective deficits in the expression of striatal-enriched mRNAs in Huntington\u2019s disease. J Neurochem 96:743\u2013757","journal-title":"J Neurochem"},{"key":"8715_CR38","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T et al (2007) Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16:1845\u20131861","journal-title":"Hum Mol Genet"},{"key":"8715_CR39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1601-183X.2007.00350.x","volume":"7","author":"A Hodges","year":"2008","unstructured":"Hodges A, Hughes G, Brooks S, Elliston L, Holmans P et al (2008) Brain gene expression correlates with changes in behavior in the R6\/1 mouse model of Huntington\u2019s disease. Genes Brain Behav 7:288\u2013299","journal-title":"Genes Brain Behav"},{"key":"8715_CR40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","volume":"83","author":"JH Cha","year":"2007","unstructured":"Cha JH (2007) Transcriptional signatures in Huntington\u2019s disease. Prog Neurobiol 83:228\u2013248","journal-title":"Prog Neurobiol"},{"key":"8715_CR41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2011.07.001","volume":"45","author":"T Seredenina","year":"2012","unstructured":"Seredenina T, Luthi-Carter R (2012) What have we learned from gene expression profiles in Huntington\u2019s disease? Neurobiol Dis 45:83\u201398","journal-title":"Neurobiol Dis"},{"key":"8715_CR42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","volume":"12","author":"S Gines","year":"2003","unstructured":"Gines S, Seong IS, Fossale E, Ivanova E, Trettel F et al (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington\u2019s disease knock-in mice. Hum Mol Genet 12:497\u2013508","journal-title":"Hum Mol Genet"},{"key":"8715_CR43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nbd.2009.07.014","volume":"36","author":"YS Choi","year":"2009","unstructured":"Choi YS, Lee B, Cho HY, Reyes IB, Pu XA et al (2009) CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington\u2019s disease. Neurobiol Dis 36:259\u2013268","journal-title":"Neurobiol Dis"},{"key":"8715_CR44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","volume":"30","author":"Z DeMarch","year":"2008","unstructured":"DeMarch Z, Giampa C, Patassini S, Bernardi G, Fusco FR (2008) Beneficial effects of rolipram in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 30:375\u2013387","journal-title":"Neurobiol Dis"},{"key":"8715_CR45","doi-asserted-by":"crossref","first-page":"e13417","DOI":"10.1371\/journal.pone.0013417","volume":"5","author":"C Giampa","year":"2010","unstructured":"Giampa C, Laurenti D, Anzilotti S, Bernardi G, Menniti FS et al (2010) Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington\u2019s disease. PLoS One 5:e13417","journal-title":"PLoS One"},{"key":"8715_CR46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","volume":"34","author":"M Valenza","year":"2011","unstructured":"Valenza M, Cattaneo E (2011) Emerging roles for cholesterol in Huntington\u2019s disease. Trends Neurosci 34:474\u2013486","journal-title":"Trends Neurosci"},{"key":"8715_CR47","doi-asserted-by":"crossref","unstructured":"Leoni V, Caccia C (2014) Study of cholesterol metabolism in Huntington\u2019s disease. Biochem Biophys Res Commun","DOI":"10.1016\/j.bbrc.2014.01.188"},{"key":"8715_CR48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"8715_CR49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2050-7771-1-28","volume":"1","author":"D Diamanti","year":"2013","unstructured":"Diamanti D, Mori E, Incarnato D, Malusa F, Fondelli C et al (2013) Whole gene expression profile in blood reveals multiple pathways deregulation in R6\/2 mouse model. Biomark Res 1:28","journal-title":"Biomark Res"},{"key":"8715_CR50","doi-asserted-by":"crossref","first-page":"17141","DOI":"10.1073\/pnas.1104409108","volume":"108","author":"Y Hu","year":"2011","unstructured":"Hu Y, Chopra V, Chopra R, Locascio JJ, Liao Z et al (2011) Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse. Proc Natl Acad Sci U S A 108:17141\u201317146","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR51","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","volume":"102","author":"F Borovecki","year":"2005","unstructured":"Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F et al (2005) Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease. Proc Natl Acad Sci U S A 102:11023\u201311028","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR52","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1073\/pnas.0703652104","volume":"104","author":"H Runne","year":"2007","unstructured":"Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M et al (2007) Analysis of potential transcriptomic biomarkers for Huntington\u2019s disease in peripheral blood. Proc Natl Acad Sci U S A 104:14424\u201314429","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR53","doi-asserted-by":"crossref","unstructured":"Marchina E, Misasi S, Bozzato A, Ferraboli S, Agosti C, et al. (2014) Gene expression profile in fibroblasts of Huntington\u2019s disease patients and controls. J Neurol Sci 337:42\u201346","DOI":"10.1016\/j.jns.2013.11.014"},{"key":"8715_CR54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","volume":"27","author":"PA Desplats","year":"2007","unstructured":"Desplats PA, Denny CA, Kass KE, Gilmartin T, Head SR et al (2007) Glycolipid and ganglioside metabolism imbalances in Huntington\u2019s disease. Neurobiol Dis 27:265\u2013277","journal-title":"Neurobiol Dis"},{"key":"8715_CR55","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","volume":"27","author":"AD Strand","year":"2007","unstructured":"Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L et al (2007) Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27:11758\u201311768","journal-title":"J Neurosci"},{"key":"8715_CR56","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","volume":"105","author":"EA Thomas","year":"2008","unstructured":"Thomas EA, Coppola G, Desplats PA, Tang B, Soragni E et al (2008) The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice. Proc Natl Acad Sci U S A 105:15564\u201315569","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddq548","volume":"20","author":"EA Thomas","year":"2011","unstructured":"Thomas EA, Coppola G, Tang B, Kuhn A, Kim S et al (2011) In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons. Hum Mol Genet 20:1049\u20131060","journal-title":"Hum Mol Genet"},{"key":"8715_CR58","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/WNL.55.9.1249","volume":"55","author":"P Calabresi","year":"2000","unstructured":"Calabresi P, Centonze D, Bernardi G (2000) Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum. Neurology 55:1249\u20131255","journal-title":"Neurology"},{"key":"8715_CR59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke RE, O'Malley K (2013) Axon degeneration in Parkinson\u2019s disease. Exp Neurol 246:72\u201383","journal-title":"Exp Neurol"},{"key":"8715_CR60","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I Tunez","year":"2010","unstructured":"Tunez I, Tasset I, Perez-De La Cruz V, Santamaria A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future. Molecules 15:878\u2013916","journal-title":"Molecules"},{"key":"8715_CR61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ng0494-409","volume":"6","author":"H Telenius","year":"1994","unstructured":"Telenius H, Kremer B, Goldberg YP, Theilmann J, Andrew SE et al (1994) Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet 6:409\u2013414","journal-title":"Nat Genet"},{"key":"8715_CR62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1752-0509-4-29","volume":"4","author":"JM Lee","year":"2010","unstructured":"Lee JM, Zhang J, Su AI, Walker JR, Wiltshire T et al (2010) A novel approach to investigate tissue-specific trinucleotide repeat instability. BMC Syst Biol 4:29","journal-title":"BMC Syst Biol"},{"key":"8715_CR63","doi-asserted-by":"crossref","unstructured":"Mason AG, Tome S, Simard JP, Libby RT, Bammler TK, et al. (2014) Expression levels of DNA replication and repair genes predict regional somatic repeat instability in the brain but are not altered by polyglutamine disease protein expression or age. Hum Mol Genet 23:1606\u20131618","DOI":"10.1093\/hmg\/ddt551"},{"key":"8715_CR64","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","volume":"137","author":"H Jeong","year":"2009","unstructured":"Jeong H, Then F, Melia TJ Jr, Mazzulli JR, Cui L et al (2009) Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 137:60\u201372","journal-title":"Cell"},{"key":"8715_CR65","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/11.17.1939","volume":"11","author":"EY Chan","year":"2002","unstructured":"Chan EY, Luthi-Carter R, Strand A, Solano SM, Hanson SA et al (2002) Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington\u2019s disease. Hum Mol Genet 11:1939\u20131951","journal-title":"Hum Mol Genet"},{"key":"8715_CR66","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/hmg\/dds132","volume":"21","author":"B Tang","year":"2012","unstructured":"Tang B, Becanovic K, Desplats PA, Spencer B, Hill AM et al (2012) Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease. Hum Mol Genet 21:3097\u20133111","journal-title":"Hum Mol Genet"},{"key":"8715_CR67","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/hmg\/ddr195","volume":"20","author":"JC Jacobsen","year":"2011","unstructured":"Jacobsen JC, Gregory GC, Woda JM, Thompson MN, Coser KR et al (2011) HD CAG-correlated gene expression changes support a simple dominant gain of function. Hum Mol Genet 20:2846\u20132860","journal-title":"Hum Mol Genet"},{"key":"8715_CR68","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/hmg\/ddt176","volume":"22","author":"JM Lee","year":"2013","unstructured":"Lee JM, Galkina EI, Levantovsky RM, Fossale E, Anne Anderson M et al (2013) Dominant effects of the Huntington\u2019s disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy. Hum Mol Genet 22:3227\u20133238","journal-title":"Hum Mol Genet"},{"key":"8715_CR69","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nmeth.1710","volume":"8","author":"A Kuhn","year":"2011","unstructured":"Kuhn A, Thu D, Waldvogel HJ, Faull RL, Luthi-Carter R (2011) Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain. Nat Methods 8:945\u2013947","journal-title":"Nat Methods"},{"key":"8715_CR70","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1177\/147323001003800510","volume":"38","author":"L Lovrecic","year":"2010","unstructured":"Lovrecic L, Slavkov I, Dzeroski S, Peterlin B (2010) ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2): a new potential biomarker in Huntington\u2019s disease. J Int Med Res 38:1653\u20131662","journal-title":"J Int Med Res"},{"key":"8715_CR71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2012.11.011","volume":"55","author":"RK Chaturvedi","year":"2013","unstructured":"Chaturvedi RK, Beal MF (2013) Mitochondria targeted therapeutic approaches in Parkinson\u2019s and Huntington\u2019s diseases. Mol Cell Neurosci 55:101\u2013114","journal-title":"Mol Cell Neurosci"},{"key":"8715_CR72","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pgen.0030135","volume":"3","author":"JM Lee","year":"2007","unstructured":"Lee JM, Ivanova EV, Seong IS, Cashorali T, Kohane I et al (2007) Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism. PLoS Genet 3:e135","journal-title":"PLoS Genet"},{"key":"8715_CR73","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm.2828","volume":"18","author":"M Jakovcevski","year":"2012","unstructured":"Jakovcevski M, Akbarian S (2012) Epigenetic mechanisms in neurological disease. Nat Med 18:1194\u20131204","journal-title":"Nat Med"},{"key":"8715_CR74","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(09)70262-5","volume":"8","author":"RG Urdinguio","year":"2009","unstructured":"Urdinguio RG, Sanchez-Mut JV, Esteller M (2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 8:1056\u20131072","journal-title":"Lancet Neurol"},{"key":"8715_CR75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","volume":"13","author":"RN Saha","year":"2006","unstructured":"Saha RN, Pahan K (2006) HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 13:539\u2013550","journal-title":"Cell Death Differ"},{"key":"8715_CR76","doi-asserted-by":"crossref","unstructured":"Valor LM, Guiretti D (2014) What\u2019s wrong with epigenetics in Huntington\u2019s disease? Neuropharmacology 80C:103\u2013114","DOI":"10.1016\/j.neuropharm.2013.10.025"},{"key":"8715_CR77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fncel.2013.00265","volume":"7","author":"S Maciotta","year":"2013","unstructured":"Maciotta S, Meregalli M, Torrente Y (2013) The involvement of microRNAs in neurodegenerative diseases. Front Cell Neurosci 7:265","journal-title":"Front Cell Neurosci"},{"key":"8715_CR78","doi-asserted-by":"crossref","unstructured":"Stroynowska-Czerwinska A, Fiszer A, Krzyzosiak WJ (2014) The panorama of miRNA-mediated mechanisms in mammalian cells. Cell Mol Life Sci","DOI":"10.1007\/s00018-013-1551-6"},{"key":"8715_CR79","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"R Johnson","year":"2008","unstructured":"Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E et al (2008) A microRNA-based gene dysregulation pathway in Huntington\u2019s disease. Neurobiol Dis 29:438\u2013445","journal-title":"Neurobiol Dis"},{"key":"8715_CR80","doi-asserted-by":"crossref","first-page":"e1002481","DOI":"10.1371\/journal.pgen.1002481","volume":"8","author":"M Banez-Coronel","year":"2012","unstructured":"Banez-Coronel M, Porta S, Kagerbauer B, Mateu-Huertas E, Pantano L et al (2012) A pathogenic mechanism in Huntington\u2019s disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genet 8:e1002481","journal-title":"PLoS Genet"},{"key":"8715_CR81","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M et al (2003) Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35:76\u201383","journal-title":"Nat Genet"},{"key":"8715_CR82","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1093\/hmg\/ddq358","volume":"19","author":"E Marcora","year":"2010","unstructured":"Marcora E, Kennedy MB (2010) The Huntington\u2019s disease mutation impairs Huntingtin\u2019s role in the transport of NF-kappaB from the synapse to the nucleus. Hum Mol Genet 19:4373\u20134384","journal-title":"Hum Mol Genet"},{"key":"8715_CR83","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jmg.2009.066399","volume":"46","author":"M Futter","year":"2009","unstructured":"Futter M, Diekmann H, Schoenmakers E, Sadiq O, Chatterjee K et al (2009) Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors. J Med Genet 46:438\u2013446","journal-title":"J Med Genet"},{"key":"8715_CR84","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ et al (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97:6763\u20136768","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR85","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/8.9.1647","volume":"8","author":"JM Boutell","year":"1999","unstructured":"Boutell JM, Thomas P, Neal JW, Weston VJ, Duce J et al (1999) Aberrant interactions of transcriptional repressor proteins with the Huntington\u2019s disease gene product, huntingtin. Hum Mol Genet 8:1647\u20131655","journal-title":"Hum Mol Genet"},{"key":"8715_CR86","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","volume":"96","author":"A Kazantsev","year":"1999","unstructured":"Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D, Housman D (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A 96:11404\u201311409","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR87","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","volume":"24","author":"CC Huang","year":"1998","unstructured":"Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel JP et al (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet 24:217\u2013233","journal-title":"Somat Cell Mol Genet"},{"key":"8715_CR88","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1073\/pnas.98.4.1811","volume":"98","author":"S Holbert","year":"2001","unstructured":"Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C et al (2001) The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington\u2019s disease pathogenesis. Proc Natl Acad Sci U S A 98:1811\u20131816","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR89","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S et al (2005) Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J Neurosci 25:9932\u20139939","journal-title":"J Neurosci"},{"key":"8715_CR90","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","volume":"24","author":"K Obrietan","year":"2004","unstructured":"Obrietan K, Hoyt KR (2004) CRE-mediated transcription is increased in Huntington\u2019s disease transgenic mice. J Neurosci 24:791\u2013796","journal-title":"J Neurosci"},{"key":"8715_CR91","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","volume":"279","author":"KL Sugars","year":"2004","unstructured":"Sugars KL, Brown R, Cook LJ, Swartz J, Rubinsztein DC (2004) Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington\u2019s disease that contributes to polyglutamine pathogenesis. J Biol Chem 279:4988\u20134999","journal-title":"J Biol Chem"},{"key":"8715_CR92","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1096\/fj.12-219220","volume":"27","author":"B Lu","year":"2013","unstructured":"Lu B, Palacino J (2013) A novel human embryonic stem cell-derived Huntington\u2019s disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. FASEB J 27:1820\u20131829","journal-title":"FASEB J"},{"key":"8715_CR93","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/ncomms3753","volume":"4","author":"J Leitman","year":"2013","unstructured":"Leitman J, Ulrich Hartl F, Lederkremer GZ (2013) Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress. Nat Commun 4:2753","journal-title":"Nat Commun"},{"key":"8715_CR94","doi-asserted-by":"crossref","unstructured":"Tian J, Yan YP, Zhou R, Lou HF, Rong Y, et al. (2013) Soluble N-terminal fragment of mutant Huntingtin protein impairs mitochondrial axonal transport in cultured hippocampal neurons. Neurosci Bull","DOI":"10.1007\/s12264-013-1393-0"},{"key":"8715_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","volume":"238","author":"M Arrasate","year":"2012","unstructured":"Arrasate M, Finkbeiner S (2012) Protein aggregates in Huntington\u2019s disease. Exp Neurol 238:1\u201311","journal-title":"Exp Neurol"},{"key":"8715_CR96","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","volume":"11","author":"ZX Yu","year":"2002","unstructured":"Yu ZX, Li SH, Nguyen HP, Li XJ (2002) Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum Mol Genet 11:905\u2013914","journal-title":"Hum Mol Genet"},{"key":"8715_CR97","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neuroscience.2004.10.037","volume":"131","author":"SJ Tallaksen-Greene","year":"2005","unstructured":"Tallaksen-Greene SJ, Crouse AB, Hunter JM, Detloff PJ, Albin RL (2005) Neuronal intranuclear inclusions and neuropil aggregates in HdhCAG(150) knockin mice. Neuroscience 131:843\u2013852","journal-title":"Neuroscience"},{"key":"8715_CR98","first-page":"560","volume":"30","author":"SY Cong","year":"2005","unstructured":"Cong SY, Pepers BA, Evert BO, Rubinsztein DC, Roos RA et al (2005) Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci 30:560\u2013571","journal-title":"Mol Cell Neurosci"},{"key":"8715_CR99","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mcn.2011.11.003","volume":"49","author":"YJ Choi","year":"2012","unstructured":"Choi YJ, Kim SI, Lee JW, Kwon YS, Lee HJ et al (2012) Suppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestration and apoptotic cell death. Mol Cell Neurosci 49:127\u2013137","journal-title":"Mol Cell Neurosci"},{"key":"8715_CR100","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG et al (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\u2019s disease. Science 296:2238\u20132243","journal-title":"Science"},{"key":"8715_CR101","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","volume":"22","author":"SH Li","year":"2002","unstructured":"Li SH, Cheng AL, Zhou H, Lam S, Rao M et al (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 22:1277\u20131287","journal-title":"Mol Cell Biol"},{"key":"8715_CR102","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1111\/j.1460-9568.2006.04871.x","volume":"23","author":"G Sadri-Vakili","year":"2006","unstructured":"Sadri-Vakili G, Menon AS, Farrell LA, Keller-McGandy CE, Cantuti-Castelvetri I et al (2006) Huntingtin inclusions do not down-regulate specific genes in the R6\/2 Huntington\u2019s disease mouse. Eur J Neurosci 23:3171\u20133175","journal-title":"Eur J Neurosci"},{"key":"8715_CR103","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","volume":"28","author":"CL Benn","year":"2008","unstructured":"Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP et al (2008) Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J Neurosci 28:10720\u201310733","journal-title":"J Neurosci"},{"key":"8715_CR104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N et al (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59\u201369","journal-title":"Cell"},{"key":"8715_CR105","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/emboj.2008.23","volume":"27","author":"T Yamanaka","year":"2008","unstructured":"Yamanaka T, Miyazaki H, Oyama F, Kurosawa M, Washizu C et al (2008) Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor. EMBO J 27:827\u2013839","journal-title":"EMBO J"},{"key":"8715_CR106","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/emboj.2010.117","volume":"29","author":"JD Godin","year":"2010","unstructured":"Godin JD, Poizat G, Hickey MA, Maschat F, Humbert S (2010) Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington\u2019s disease. EMBO J 29:2433\u20132445","journal-title":"EMBO J"},{"key":"8715_CR107","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/rns.2011.018","volume":"22","author":"CA Saura","year":"2011","unstructured":"Saura CA, Valero J (2011) The role of CREB signaling in Alzheimer\u2019s disease and other cognitive disorders. Rev Neurosci 22:153\u2013169","journal-title":"Rev Neurosci"},{"key":"8715_CR108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/1471-2164-12-463","volume":"12","author":"M Datta","year":"2011","unstructured":"Datta M, Choudhury A, Lahiri A, Bhattacharyya NP (2011) Genome wide gene expression regulation by HIP1 Protein Interactor, HIPPI: prediction and validation. BMC Genomics 12:463","journal-title":"BMC Genomics"},{"key":"8715_CR109","doi-asserted-by":"crossref","first-page":"e54222","DOI":"10.1371\/journal.pone.0054222","volume":"8","author":"A Jovicic","year":"2013","unstructured":"Jovicic A, Zaldivar Jolissaint JF, Moser R, Silva Santos Mde F, Luthi-Carter R (2013) MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington\u2019s disease-related mechanisms. PLoS One 8:e54222","journal-title":"PLoS One"},{"key":"8715_CR110","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","volume":"27","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Belyaev N, Conforti P, Ooi L, Tartari M et al (2007) Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington\u2019s disease. J Neurosci 27:6972\u20136983","journal-title":"J Neurosci"},{"key":"8715_CR111","doi-asserted-by":"crossref","first-page":"e41423","DOI":"10.1371\/journal.pone.0041423","volume":"7","author":"KN McFarland","year":"2012","unstructured":"McFarland KN, Das S, Sun TT, Leyfer D, Xia E et al (2012) Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington\u2019s disease. PLoS One 7:e41423","journal-title":"PLoS One"},{"key":"8715_CR112","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JHD-2012-120020","volume":"1","author":"L Riva","year":"2012","unstructured":"Riva L, Koeva M, Yildirim F, Pirhaji L, Dinesh D et al (2012) Poly-glutamine expanded huntingtin dramatically alters the genome wide binding of HSF1. J Huntingtons Dis 1:33\u201345","journal-title":"J Huntingtons Dis"},{"key":"8715_CR113","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00401-013-1103-z","volume":"125","author":"J Lee","year":"2013","unstructured":"Lee J, Hwang YJ, Shin JY, Lee WC, Wie J et al (2013) Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington\u2019s disease. Acta Neuropathol 125:727\u2013739","journal-title":"Acta Neuropathol"},{"key":"8715_CR114","doi-asserted-by":"crossref","unstructured":"Adachi M, Monteggia LM (2014) Decoding transcriptional repressor complexes in the adult central nervous system. Neuropharmacology 80C:45\u201352","DOI":"10.1016\/j.neuropharm.2013.12.024"},{"key":"8715_CR115","doi-asserted-by":"crossref","unstructured":"Johnson R, Richter N, Jauch R, Gaughwin PM, Zuccato C, et al. (2010) The Human Accelerated Region 1 noncoding RNA is repressed by REST in Huntington\u2019s disease. Physiol Genomics 41:269\u2013274","DOI":"10.1152\/physiolgenomics.00019.2010"},{"key":"8715_CR116","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jnc.12090","volume":"124","author":"C Soldati","year":"2013","unstructured":"Soldati C, Bithell A, Johnston C, Wong KY, Stanton LW et al (2013) Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington\u2019s disease. J Neurochem 124:418\u2013430","journal-title":"J Neurochem"},{"key":"8715_CR117","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1002\/ajmg.a.36174","volume":"161A","author":"AK Fevre Le","year":"2013","unstructured":"Le Fevre AK, Taylor S, Malek NH, Horn D, Carr CW et al (2013) FOXP1 mutations cause intellectual disability and a recognizable phenotype. Am J Med Genet A 161A:3166\u20133175","journal-title":"Am J Med Genet A"},{"key":"8715_CR118","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/hmg\/ddh144","volume":"13","author":"DG Hay","year":"2004","unstructured":"Hay DG, Sathasivam K, Tobaben S, Stahl B, Marber M et al (2004) Progressive decrease in chaperone protein levels in a mouse model of Huntington\u2019s disease and induction of stress proteins as a therapeutic approach. Hum Mol Genet 13:1389\u20131405","journal-title":"Hum Mol Genet"},{"key":"8715_CR119","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI57413","volume":"121","author":"J Labbadia","year":"2011","unstructured":"Labbadia J, Cunliffe H, Weiss A, Katsyuba E, Sathasivam K et al (2011) Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. J Clin Invest 121:3306\u20133319","journal-title":"J Clin Invest"},{"key":"8715_CR120","doi-asserted-by":"crossref","first-page":"e42878","DOI":"10.1371\/journal.pone.0042878","volume":"7","author":"EK Lucas","year":"2012","unstructured":"Lucas EK, Dougherty SE, McMeekin LJ, Trinh AT, Reid CS et al (2012) Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking pgc-1alpha. PLoS One 7:e42878","journal-title":"PLoS One"},{"key":"8715_CR121","doi-asserted-by":"crossref","first-page":"40545","DOI":"10.1074\/jbc.M402229200","volume":"279","author":"JM Levenson","year":"2004","unstructured":"Levenson JM, O'Riordan KJ, Brown KD, Trinh MA, Molfese DL et al (2004) Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 279:40545\u201340559","journal-title":"J Biol Chem"},{"key":"8715_CR122","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.1186088","volume":"328","author":"S Peleg","year":"2010","unstructured":"Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S et al (2010) Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328:753\u2013756","journal-title":"Science"},{"key":"8715_CR123","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1101\/lm.029363.112","volume":"20","author":"S Parkel","year":"2013","unstructured":"Parkel S, Lopez-Atalaya JP, Barco A (2013) Histone H3 lysine methylation in cognition and intellectual disability disorders. Learn Mem 20:570\u2013579","journal-title":"Learn Mem"},{"key":"8715_CR124","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/hmg\/ddt214","volume":"22","author":"F Wang","year":"2013","unstructured":"Wang F, Yang Y, Lin X, Wang JQ, Wu YS et al (2013) Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington\u2019s disease. Hum Mol Genet 22:3641\u20133653","journal-title":"Hum Mol Genet"},{"key":"8715_CR125","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","volume":"283","author":"F Giorgini","year":"2008","unstructured":"Giorgini F, Moller T, Kwan W, Zwilling D, Wacker JL et al (2008) Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment. J Biol Chem 283:7390\u20137400","journal-title":"J Biol Chem"},{"key":"8715_CR126","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ng907","volume":"31","author":"SK Kurdistani","year":"2002","unstructured":"Kurdistani SK, Robyr D, Tavazoie S, Grunstein M (2002) Genome-wide binding map of the histone deacetylase Rpd3 in yeast. Nat Genet 31:248\u2013254","journal-title":"Nat Genet"},{"key":"8715_CR127","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1074\/jbc.M110.101527","volume":"286","author":"E Tauber","year":"2011","unstructured":"Tauber E, Miller-Fleming L, Mason RP, Kwan W, Clapp J et al (2011) Functional gene expression profiling in yeast implicates translational dysfunction in mutant huntingtin toxicity. J Biol Chem 286:410\u2013419","journal-title":"J Biol Chem"},{"key":"8715_CR128","doi-asserted-by":"crossref","first-page":"e1001717","DOI":"10.1371\/journal.pbio.1001717","volume":"11","author":"M Mielcarek","year":"2013","unstructured":"Mielcarek M, Landles C, Weiss A, Bradaia A, Seredenina T et al (2013) HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol 11:e1001717","journal-title":"PLoS Biol"},{"key":"8715_CR129","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2012.09.037","volume":"151","author":"R Sando 3rd","year":"2012","unstructured":"Sando R 3rd, Gounko N, Pieraut S, Liao L, Yates J 3rd et al (2012) HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell 151:821\u2013834","journal-title":"Cell"},{"key":"8715_CR130","doi-asserted-by":"crossref","first-page":"e80849","DOI":"10.1371\/journal.pone.0080849","volume":"8","author":"M Mielcarek","year":"2013","unstructured":"Mielcarek M, Seredenina T, Stokes MP, Osborne GF, Landles C et al (2013) HDAC4 does not act as a protein deacetylase in the postnatal murine brain in vivo. PLoS One 8:e80849","journal-title":"PLoS One"},{"key":"8715_CR131","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","volume":"277","author":"KB Kegel","year":"2002","unstructured":"Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle E et al (2002) Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem 277:7466\u20137476","journal-title":"J Biol Chem"},{"key":"8715_CR132","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","volume":"24","author":"RJ Ferrante","year":"2004","unstructured":"Ferrante RJ, Ryu H, Kubilus JK, D'Mello S, Sugars KL et al (2004) Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington\u2019s disease. J Neurosci 24:10335\u201310342","journal-title":"J Neurosci"},{"key":"8715_CR133","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddm064","volume":"16","author":"EC Stack","year":"2007","unstructured":"Stack EC, Del Signore SJ, Luthi-Carter R, Soh BY, Goldstein DR et al (2007) Modulation of nucleosome dynamics in Huntington\u2019s disease. Hum Mol Genet 16:1164\u20131175","journal-title":"Hum Mol Genet"},{"key":"8715_CR134","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE et al (2006) ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease. Proc Natl Acad Sci U S A 103:19176\u201319181","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","volume":"280","author":"G Gardian","year":"2005","unstructured":"Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J et al (2005) Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington\u2019s disease. J Biol Chem 280:556\u2013563","journal-title":"J Biol Chem"},{"key":"8715_CR136","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/cdd.2011.196","volume":"19","author":"J Lee","year":"2012","unstructured":"Lee J, Hong YK, Jeon GS, Hwang YJ, Kim KY et al (2012) ATRX induction by mutant huntingtin via Cdx2 modulates heterochromatin condensation and pathology in Huntington\u2019s disease. Cell Death Differ 19:1109\u20131116","journal-title":"Cell Death Differ"},{"key":"8715_CR137","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/hmg\/ddn067","volume":"17","author":"J Lee","year":"2008","unstructured":"Lee J, Hagerty S, Cormier KA, Kim J, Kung AL et al (2008) Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation. Hum Mol Genet 17:1774\u20131782","journal-title":"Hum Mol Genet"},{"key":"8715_CR138","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nbd.2010.02.003","volume":"39","author":"NJ Buckley","year":"2010","unstructured":"Buckley NJ, Johnson R, Zuccato C, Bithell A, Cattaneo E (2010) The role of REST in transcriptional and epigenetic dysregulation in Huntington\u2019s disease. Neurobiol Dis 39:28\u201339","journal-title":"Neurobiol Dis"},{"key":"8715_CR139","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-4159.2010.07122.x","volume":"116","author":"C Soldati","year":"2011","unstructured":"Soldati C, Bithell A, Conforti P, Cattaneo E, Buckley NJ (2011) Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington\u2019s disease. J Neurochem 116:415\u2013425","journal-title":"J Neurochem"},{"key":"8715_CR140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature10716","volume":"480","author":"MB Stadler","year":"2011","unstructured":"Stadler MB, Murr R, Burger L, Ivanek R, Lienert F et al (2011) DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480:490\u2013495","journal-title":"Nature"},{"key":"8715_CR141","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/hmg\/ddr148","volume":"20","author":"E Martin","year":"2011","unstructured":"Martin E, Betuing S, Pages C, Cambon K, Auregan G et al (2011) Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington\u2019s disease: role on chromatin remodeling at the PGC-1-alpha promoter. Hum Mol Genet 20:2422\u20132434","journal-title":"Hum Mol Genet"},{"key":"8715_CR142","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"BI Bae","year":"2005","unstructured":"Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N et al (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron 47:29\u201341","journal-title":"Neuron"},{"key":"8715_CR143","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","volume":"18","author":"M Jiang","year":"2012","unstructured":"Jiang M, Wang J, Fu J, Du L, Jeong H et al (2012) Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets. Nat Med 18:153\u2013158","journal-title":"Nat Med"},{"key":"8715_CR144","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12031-011-9516-4","volume":"45","author":"JL Illuzzi","year":"2011","unstructured":"Illuzzi JL, Vickers CA, Kmiec EB (2011) Modifications of p53 and the DNA damage response in cells expressing mutant form of the protein huntingtin. J Mol Neurosci 45:256\u2013268","journal-title":"J Mol Neurosci"},{"key":"8715_CR145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s13238-011-1063-9","volume":"2","author":"CL Brooks","year":"2011","unstructured":"Brooks CL, Gu W (2011) The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2:456\u2013462","journal-title":"Protein Cell"},{"key":"8715_CR146","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1523\/JNEUROSCI.5214-12.2013","volume":"33","author":"C Brochier","year":"2013","unstructured":"Brochier C, Dennis G, Rivieccio MA, McLaughlin K, Coppola G et al (2013) Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. J Neurosci 33:8621\u20138632","journal-title":"J Neurosci"},{"key":"8715_CR147","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/cdd.2011.38","volume":"18","author":"J Lee","year":"2011","unstructured":"Lee J, Hwang YJ, Boo JH, Han D, Kwon OK et al (2011) Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington\u2019s disease. Cell Death Differ 18:1726\u20131735","journal-title":"Cell Death Differ"},{"key":"8715_CR148","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/npp.2008.172","volume":"34","author":"CA Altar","year":"2009","unstructured":"Altar CA, Vawter MP, Ginsberg SD (2009) Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology 34:18\u201354","journal-title":"Neuropsychopharmacology"},{"key":"8715_CR149","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hipo.20888","volume":"22","author":"LM Valor","year":"2012","unstructured":"Valor LM, Barco A (2012) Hippocampal gene profiling: toward a systems biology of the hippocampus. Hippocampus 22:929\u2013941","journal-title":"Hippocampus"},{"key":"8715_CR150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/gt.2011.170","volume":"18","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Friedlander RM (2011) Using non-coding small RNAs to develop therapies for Huntington\u2019s disease. Gene Ther 18:1139\u20131149","journal-title":"Gene Ther"},{"key":"8715_CR151","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","volume":"65","author":"V Drouet","year":"2009","unstructured":"Drouet V, Perrin V, Hassig R, Dufour N, Auregan G et al (2009) Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol 65:276\u2013285","journal-title":"Ann Neurol"},{"key":"8715_CR152","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, McBride JL, Martins I, Shen S, Xing Y et al (2009) Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice. Mol Ther 17:1053\u20131063","journal-title":"Mol Ther"},{"key":"8715_CR153","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awr333","volume":"135","author":"R Grondin","year":"2012","unstructured":"Grondin R, Kaytor MD, Ai Y, Nelson PT, Thakker DR et al (2012) Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum. Brain 135:1197\u20131209","journal-title":"Brain"},{"key":"8715_CR154","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/hmg\/ddl467","volume":"16","author":"AN Strehlow","year":"2007","unstructured":"Strehlow AN, Li JZ, Myers RM (2007) Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space. Hum Mol Genet 16:391\u2013409","journal-title":"Hum Mol Genet"},{"key":"8715_CR155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2202-9-38","volume":"9","author":"H Zhang","year":"2008","unstructured":"Zhang H, Das S, Li QZ, Dragatsis I, Repa J et al (2008) Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts. BMC Neurosci 9:38","journal-title":"BMC Neurosci"},{"key":"8715_CR156","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/mt.2011.185","volume":"19","author":"RL Boudreau","year":"2011","unstructured":"Boudreau RL, Spengler RM, Davidson BL (2011) Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington\u2019s disease. Mol Ther 19:2169\u20132177","journal-title":"Mol Ther"},{"key":"8715_CR157","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1083\/jcb.200510065","volume":"172","author":"A Yamamoto","year":"2006","unstructured":"Yamamoto A, Cremona ML, Rothman JE (2006) Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 172:719\u2013731","journal-title":"J Cell Biol"},{"key":"8715_CR158","doi-asserted-by":"crossref","first-page":"37445","DOI":"10.1074\/jbc.M110.125542","volume":"285","author":"H Varma","year":"2010","unstructured":"Varma H, Yamamoto A, Sarantos MR, Hughes RE, Stockwell BR (2010) Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway. J Biol Chem 285:37445\u201337457","journal-title":"J Biol Chem"},{"key":"8715_CR159","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1460-9568.2005.03895.x","volume":"21","author":"AJ Morton","year":"2005","unstructured":"Morton AJ, Hunt MJ, Hodges AK, Lewis PD, Redfern AJ et al (2005) A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington\u2019s disease. Eur J Neurosci 21:855\u2013870","journal-title":"Eur J Neurosci"},{"key":"8715_CR160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","volume":"51","author":"E Hockly","year":"2002","unstructured":"Hockly E, Cordery PM, Woodman B, Mahal A, van Dellen A et al (2002) Environmental enrichment slows disease progression in R6\/2 Huntington\u2019s disease mice. Ann Neurol 51:235\u2013242","journal-title":"Ann Neurol"},{"key":"8715_CR161","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","volume":"24","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A et al (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism. J Neurosci 24:2270\u20132276","journal-title":"J Neurosci"},{"key":"8715_CR162","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","volume":"29","author":"J Nithianantharajah","year":"2008","unstructured":"Nithianantharajah J, Barkus C, Murphy M, Hannan AJ (2008) Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington\u2019s disease transgenic mice. Neurobiol Dis 29:490\u2013504","journal-title":"Neurobiol Dis"},{"key":"8715_CR163","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","volume":"404","author":"A Dellen van","year":"2000","unstructured":"van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ (2000) Delaying the onset of Huntington\u2019s in mice. Nature 404:721\u2013722","journal-title":"Nature"},{"key":"8715_CR164","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrn1970","volume":"7","author":"J Nithianantharajah","year":"2006","unstructured":"Nithianantharajah J, Hannan AJ (2006) Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci 7:697\u2013709","journal-title":"Nat Rev Neurosci"},{"key":"8715_CR165","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/NEN.0b013e3181ea167f","volume":"69","author":"CL Benn","year":"2010","unstructured":"Benn CL, Luthi-Carter R, Kuhn A, Sadri-Vakili G, Blankson KL et al (2010) Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease. J Neuropathol Exp Neurol 69:817\u2013827","journal-title":"J Neuropathol Exp Neurol"},{"key":"8715_CR166","doi-asserted-by":"crossref","first-page":"12880","DOI":"10.1073\/pnas.97.23.12880","volume":"97","author":"C Rampon","year":"2000","unstructured":"Rampon C, Jiang CH, Dong H, Tang YP, Lockhart DJ et al (2000) Effects of environmental enrichment on gene expression in the brain. Proc Natl Acad Sci U S A 97:12880\u201312884","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR167","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2005.01.015","volume":"120","author":"O Lazarov","year":"2005","unstructured":"Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z et al (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120:701\u2013713","journal-title":"Cell"},{"key":"8715_CR168","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/emboj.2011.299","volume":"30","author":"JP Lopez-Atalaya","year":"2011","unstructured":"Lopez-Atalaya JP, Ciccarelli A, Viosca J, Valor LM, Jimenez-Minchan M et al (2011) CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. EMBO J 30:4287\u20134298","journal-title":"EMBO J"},{"key":"8715_CR169","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci 6:919\u2013930","journal-title":"Nat Rev Neurosci"},{"key":"8715_CR170","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","volume":"30","author":"Y Xie","year":"2010","unstructured":"Xie Y, Hayden MR, Xu B (2010) BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice. J Neurosci 30:14708\u201314718","journal-title":"J Neurosci"},{"key":"8715_CR171","doi-asserted-by":"crossref","first-page":"e64037","DOI":"10.1371\/journal.pone.0064037","volume":"8","author":"C Giampa","year":"2013","unstructured":"Giampa C, Montagna E, Dato C, Melone MA, Bernardi G et al (2013) Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington\u2019s disease. PLoS One 8:e64037","journal-title":"PLoS One"},{"key":"8715_CR172","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1093\/hmg\/ddn255","volume":"17","author":"B Mugat","year":"2008","unstructured":"Mugat B, Parmentier ML, Bonneaud N, Chan HY, Maschat F (2008) Protective role of Engrailed in a Drosophila model of Huntington\u2019s disease. Hum Mol Genet 17:3601\u20133616","journal-title":"Hum Mol Genet"},{"key":"8715_CR173","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","volume":"23","author":"RJ Ferrante","year":"2003","unstructured":"Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A et al (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice. J Neurosci 23:9418\u20139427","journal-title":"J Neurosci"},{"key":"8715_CR174","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","volume":"107","author":"R Luthi-Carter","year":"2010","unstructured":"Luthi-Carter R, Taylor DM, Pallos J, Lambert E, Amore A et al (2010) SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci U S A 107:7927\u20137932","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8715_CR175","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M et al (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325:834\u2013840","journal-title":"Science"},{"key":"8715_CR176","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ncomms2921","volume":"4","author":"B Pang","year":"2013","unstructured":"Pang B, Qiao X, Janssen L, Velds A, Groothuis T et al (2013) Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat Commun 4:1908","journal-title":"Nat Commun"},{"key":"8715_CR177","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/138920110790909650","volume":"11","author":"Y Nagai","year":"2010","unstructured":"Nagai Y, Fujikake N, Popiel HA, Wada K (2010) Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases. Curr Pharm Biotechnol 11:188\u2013197","journal-title":"Curr Pharm Biotechnol"},{"key":"8715_CR178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/sqb.2010.75.039","volume":"75","author":"MJ Guertin","year":"2010","unstructured":"Guertin MJ, Petesch SJ, Zobeck KL, Min IM, Lis JT (2010) Drosophila heat shock system as a general model to investigate transcriptional regulation. Cold Spring Harb Symp Quant Biol 75:1\u20139","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"8715_CR179","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jnc.12348","volume":"127","author":"P Conforti","year":"2013","unstructured":"Conforti P, Zuccato C, Gaudenzi G, Ieraci A, Camnasio S et al (2013) Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington\u2019s disease models. J Neurochem 127:22\u201335","journal-title":"J Neurochem"},{"key":"8715_CR180","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/stem.1430","volume":"31","author":"J Charbord","year":"2013","unstructured":"Charbord J, Poydenot P, Bonnefond C, Feyeux M, Casagrande F et al (2013) High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes. Stem Cells 31:1816\u20131828","journal-title":"Stem Cells"},{"key":"8715_CR181","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2012.08.005","volume":"1481","author":"B Friedrich","year":"2012","unstructured":"Friedrich B, Euler P, Ziegler R, Kuhn A, Landwehrmeyer BG et al (2012) Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseases. Brain Res 1481:37\u201348","journal-title":"Brain Res"},{"key":"8715_CR182","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2012.03.080","volume":"517","author":"P Euler","year":"2012","unstructured":"Euler P, Friedrich B, Ziegler R, Kuhn A, Lindenberg KS et al (2012) Gene expression analysis on a single cell level in Purkinje cells of Huntington\u2019s disease transgenic mice. Neurosci Lett 517:7\u201312","journal-title":"Neurosci Lett"},{"key":"8715_CR183","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2010.09.003","volume":"31","author":"A Fischer","year":"2010","unstructured":"Fischer A, Sananbenesi F, Mungenast A, Tsai LH (2010) Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci 31:605\u2013617","journal-title":"Trends Pharmacol Sci"},{"key":"8715_CR184","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.2174\/13816128113199990382","volume":"19","author":"LM Valor","year":"2013","unstructured":"Valor LM, Viosca J, Lopez-Atalaya JP, Barco A (2013) Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. Curr Pharm Des 19:5051\u20135064","journal-title":"Curr Pharm Des"},{"key":"8715_CR185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuint.2011.11.001","volume":"60","author":"N Osada","year":"2012","unstructured":"Osada N, Kosuge Y, Oguchi S, Miyagishi H, Ishige K et al (2012) Protective action of mithramycin against neurodegeneration and impairment of synaptic plasticity in the hippocampal CA1 area after transient global ischemia. Neurochem Int 60:47\u201354","journal-title":"Neurochem Int"},{"key":"8715_CR186","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1523\/JNEUROSCI.0710-11.2011","volume":"31","author":"SF Sleiman","year":"2011","unstructured":"Sleiman SF, Langley BC, Basso M, Berlin J, Xia L et al (2011) Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration. J Neurosci 31:6858\u20136870","journal-title":"J Neurosci"},{"key":"8715_CR187","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11010-013-1844-y","volume":"386","author":"S Paul","year":"2014","unstructured":"Paul S, Mahanta S (2014) Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door? Mol Cell Biochem 386:45\u201361","journal-title":"Mol Cell Biochem"},{"key":"8715_CR188","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","volume":"15","author":"AH Nagahara","year":"2009","unstructured":"Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE et al (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer\u2019s disease. Nat Med 15:331\u2013337","journal-title":"Nat Med"},{"key":"8715_CR189","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/cdd.2010.40","volume":"17","author":"LM Valor","year":"2010","unstructured":"Valor LM, Jancic D, Lujan R, Barco A (2010) Ultrastructural and transcriptional profiling of neuropathological misregulation of CREB function. Cell Death Differ 17:1636\u20131644","journal-title":"Cell Death Differ"},{"key":"8715_CR190","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s11481-012-9409-5","volume":"7","author":"A Borjabad","year":"2012","unstructured":"Borjabad A, Volsky DJ (2012) Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer\u2019s disease, and Multiple Sclerosis. J Neuroimmune Pharmacol 7:914\u2013926","journal-title":"J Neuroimmune Pharmacol"},{"key":"8715_CR191","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/bioinformatics\/btt007","volume":"29","author":"CL Poirel","year":"2013","unstructured":"Poirel CL, Rahman A, Rodrigues RR, Krishnan A, Addesa JR et al (2013) Reconciling differential gene expression data with molecular interaction networks. Bioinformatics 29:622\u2013629","journal-title":"Bioinformatics"},{"key":"8715_CR192","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/NEN.0b013e3181ed7a41","volume":"69","author":"B Zucker","year":"2010","unstructured":"Zucker B, Kama JA, Kuhn A, Thu D, Orlando LR et al (2010) Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease. J Neuropathol Exp Neurol 69:880\u2013895","journal-title":"J Neuropathol Exp Neurol"},{"key":"8715_CR193","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","volume":"14","author":"R Luthi-Carter","year":"2003","unstructured":"Luthi-Carter R, Apostol BL, Dunah AW, DeJohn MM, Farrell LA et al (2003) Complex alteration of NMDA receptors in transgenic Huntington\u2019s disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation. Neurobiol Dis 14:624\u2013636","journal-title":"Neurobiol Dis"},{"key":"8715_CR194","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","volume":"93","author":"S Kotliarova","year":"2005","unstructured":"Kotliarova S, Jana NR, Sakamoto N, Kurosawa M, Miyazaki H et al (2005) Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates. J Neurochem 93:641\u2013653","journal-title":"J Neurochem"},{"key":"8715_CR195","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.02.102","volume":"1088","author":"SF Crocker","year":"2006","unstructured":"Crocker SF, Costain WJ, Robertson HA (2006) DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington\u2019s mice (R6\/2) reveals neuroinflammation and insulin associations. Brain Res 1088:176\u2013186","journal-title":"Brain Res"},{"key":"8715_CR196","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","volume":"16","author":"G Sadri-Vakili","year":"2007","unstructured":"Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P et al (2007) Histones associated with downregulated genes are hypo-acetylated in Huntington\u2019s disease models. Hum Mol Genet 16:1293\u20131306","journal-title":"Hum Mol Genet"},{"key":"8715_CR197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2008.06.004","volume":"40","author":"MT Lorincz","year":"2009","unstructured":"Lorincz MT, Zawistowski VA (2009) Expanded CAG repeats in the murine Huntington\u2019s disease gene increases neuronal differentiation of embryonic and neural stem cells. Mol Cell Neurosci 40:1\u201313","journal-title":"Mol Cell Neurosci"},{"key":"8715_CR198","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nbd.2011.02.008","volume":"42","author":"B Tang","year":"2011","unstructured":"Tang B, Seredenina T, Coppola G, Kuhn A, Geschwind DH et al (2011) Gene expression profiling of R6\/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington\u2019s disease. Neurobiol Dis 42:459\u2013467","journal-title":"Neurobiol Dis"},{"key":"8715_CR199","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1093\/hmg\/dds216","volume":"21","author":"M Feyeux","year":"2012","unstructured":"Feyeux M, Bourgois-Rocha F, Redfern A, Giles P, Lefort N et al (2012) Early transcriptional changes linked to naturally occurring Huntington\u2019s disease mutations in neural derivatives of human embryonic stem cells. Hum Mol Genet 21:3883\u20133895","journal-title":"Hum Mol Genet"},{"key":"8715_CR200","doi-asserted-by":"crossref","unstructured":"Ribeiro FM, Devries RA, Hamilton A, Guimaraes IM, Cregan SP, et al. (2014) Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington\u2019s disease. Hum Mol Genet 23:2030\u20132042","DOI":"10.1093\/hmg\/ddt598"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8715-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-8715-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8715-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T15:04:23Z","timestamp":1648911863000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-8715-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["8715"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-8715-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}